Application of FeNO in the diagnostic and therapeutic algorithm of pediatric asthma From chronic cough and wheeze to personalized management
Main Article Content
Keywords
asthma; biomarkers; children; exhaled nitric oxide; T2-high inflammation
Abstract
Bronchial asthma is the most common chronic respiratory disease in children. Treatment approaches should aim to achieve disease control, reduce limiting symptoms, and improve quality of life. The routine management of patients with asthma relies on the assessment of symptoms (including persistent cough and wheezing) and spirometry results. However, these strategies do not consider the level of airway inflammation, which is a fundamental pathognomonic feature of the disease. The use of biomarkers is increasing in an effort to better understand individual asthma pathways (endotyping), offering the potential for personalized treatment with innovative biologics. Elevated levels of fractional exhaled nitric oxide (FeNO) are an indirect marker of T2 airway inflammation. FeNO is one of the few biomarkers that has been implemented in routine clinical practice because of its undeniable advantages, such as accessibility, noninvasiveness, simple implementation, and cost-effectiveness. However, the current scientific evidence in children is insufficient to recommend its universal use in the diagnosis and treatment of all patients. Considering its known limitations, FeNO can enhance therapeutic processes, particularly in children with severe asthma. High FeNO levels predict a good therapeutic response to corticosteroids and selected biologics (e.g., omalizumab and dupilumab) and indicate an increased risk of exacerbation. Similarly, measuring FeNO levels in children with recurrent wheezing can help determine the risk of future asthma development. Various factors contributing to FeNO value variability must be considered when interpreting the results. The lack of robust clinical studies is reflected in inconsistent guidelines from professional societies regarding the use of FeNO in managing childhood asthma. This review aims to evaluate the advantages, disadvantages, and potential applications of FeNO measurements in light of new findings in the field.
References
1. Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Semin Immunopathol. 2020 Feb;42(1):5-15.
https://doi.org/10.1007/s00281-020-00785-1
2. Licari A, Castagnoli R, Brambilla I, Marseglia A, Tosca MA, Marseglia GL, et al. Asthma Endotyping and Biomarkers in Childhood Asthma. Pediatr Allergy Immunol Pulmonol. 2018 June 1;31(2):44-55.
https://doi.org/10.1089/ped.2018.0886
3. Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. Journal of Allergy and Clinical Immunology. 2012 Aug 1;130(2):287-96.
https://doi.org/10.1016/j.jaci.2012.04.025
4. Jat KR, Agarwal S. Lung Function Tests in Infants and Children. Indian J Pediatr. 2023 June 1;1-8.
https://doi.org/10.1007/s12098-023-04588-8
5. Elenius V, Chawes B, Malmberg PL, Adamiec A, Ruszczyński M, Feleszko W, et al. Lung function testing and inflammation markers for wheezing preschool children: A systematic review for the EAACI Clinical Practice Recommendations on Diagnostics of Preschool Wheeze. Pediatric Allergy and Immunology. 2021;32(3):501-13.
https://doi.org/10.1111/pai.13418
6. Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL. Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children. Chest. 2011 July;140(1):100-7.
https://doi.org/10.1378/chest.10-2794
7. Pande V, Thakur M. Emphasis on Quality of Life in Children and Adolescents With Bronchial Asthma. Cureus. 2024 Sept;16(9):e68762.
https://doi.org/10.7759/cureus.68762
8. Bhagat D, Fagnano M, Halterman JS, Reznik M. Asthma Symptoms, Interactive Physical Play, and Socio-emotional and Academic Outcomes in Urban Children with Persistent Asthma. J Asthma. 2019 July;56(7):711-8.
https://doi.org/10.1080/02770903.2018.1488978
9. Allen CW, Diamond-Myrsten S, Rollins LK. School Absenteeism in Children and Adolescents. Am Fam Physician. 2018 Dec 15;98(12):738-44.
10. Koinis-Mitchell D, Kopel SJ, Farrow ML, McQuaid EL, Nassau JH. Asthma and Academic Performance in Urban Children. Ann Allergy Asthma Immunol. 2019 May;122(5):471-7.
https://doi.org/10.1016/j.anai.2019.02.030
11. Hollander Z, DeMarco ML, Sadatsafavi M, McManus BM, Ng RT, Sin DD. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care. Chest. 2017 Feb;151(2):455-67.
https://doi.org/10.1016/j.chest.2016.09.012
12. Moreno-Jiménez E, Morgado N, Gómez-García M, Sanz C, Gil-Melcón M, Isidoro-García M, et al. TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences. 2025 Jan;26(3):1227.
https://doi.org/10.3390/ijms26031227
13. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018 27;391(10118):350-400.
https://doi.org/10.1016/S0140-6736(17)30879-6
14. Farne HA, Wilson A, Powell C, Bax L, Milan SJ. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017 Sept 21;9:CD010834.
https://doi.org/10.1002/14651858.CD010834.pub3
15. Agache I, Strasser DS, Klenk A, Agache C, Farine H, Ciobanu C, et al. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics. Allergy. 2016 Aug;71(8):1192-202.
https://doi.org/10.1111/all.12906
16. Williams TJ. Eotaxin-1 (CCL11). Front Immunol. 2015;6:84.
https://doi.org/10.3389/fimmu.2015.00084
17. Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG. Treatable Mechanisms in Asthma. Mol Diagn Ther. 2021;25(2):111-21.
https://doi.org/10.1007/s40291-021-00514-w
18. Jesenak M, Zelieskova M, Babusikova E. Oxidative Stress and Bronchial Asthma in Children-Causes or Consequences? Front Pediatr. 2017;5:162.
https://doi.org/10.3389/fped.2017.00162
19. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1376-81.
https://doi.org/10.1164/ajrccm.164.8.2101145
20. Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Agency for Healthcare Research and Quality; 2017 [cited 2021 Mar 19]. Available from: https://effectivehealthcare.ahrq.gov/topics/asthma-nitric-oxide/research/
https://doi.org/10.23970/AHRQEPCCER197
21. Hoyte FCL, Gross LM, Katial RK. Exhaled Nitric Oxide: An Update. Immunol Allergy Clin North Am. 2018 Nov;38(4):573-85.
https://doi.org/10.1016/j.iac.2018.06.001
22. Rao DR, Phipatanakul W. An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol. 2016 May;12(5):521-30.
https://doi.org/10.1586/1744666X.2016.1141049
23. Loewenthal L, Menzies-Gow A. FeNO in Asthma. Semin Respir Crit Care Med. 2022 Oct;43(5):635-45.
https://doi.org/10.1055/s-0042-1743290
24. Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr. 1997 Mar;130(3):423-7.
https://doi.org/10.1016/S0022-3476(97)70204-X
25. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997 Sept;131(3):381-5.
https://doi.org/10.1016/S0022-3476(97)80062-5
26. Nystad W, Samuelsen SO, Nafstad P, Edvardsen E, Stensrud T, Jaakkola JJK. Feasibility of measuring lung function in preschool children. Thorax. 2002 Dec;57(12):1021-7.
https://doi.org/10.1136/thorax.57.12.1021
27. Fenu G, Calogero C, Lombardi E. Lung Function Tests in Preschool Children. Turk Thorac J. 2015 Oct;16(4):185-8.
https://doi.org/10.5152/ttd.2015.5038
28. Gaffin JM, Shotola NL, Martin TR, Phipatanakul W. Clinically Useful Spirometry in Preschool-Aged Children: Evaluation of the 2007 American Thoracic Society Guidelines. J Asthma. 2010 Sept;47(7):762-7.
https://doi.org/10.3109/02770903.2010.485664
29. Heijkenskjöld-Rentzhog C, Kalm-Stephens P, Nordvall L, Malinovschi A, Alving K. New method for single-breath fraction of exhaled nitric oxide measurement with improved feasibility in preschool children with asthma. Pediatr Allergy Immunol. 2015 Nov;26(7):662-7.
https://doi.org/10.1111/pai.12447
30. Jackson DJ, Virnig CM, Gangnon RE, Evans MD, Roberg KA, Anderson EL, et al. Fractional Exhaled Nitric Oxide (FeNO) Measurements are Most Closely Associated with Allergic Sensitization in School Aged Children. J Allergy Clin Immunol. 2009 Nov;124(5):949-53.
https://doi.org/10.1016/j.jaci.2009.07.024
31. Vilmann L, Buchvald F, Green K, Nielsen KG. Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children. Respiratory Medicine. 2017 Dec 1;133:42-7.
https://doi.org/10.1016/j.rmed.2017.10.027
32. Sayão LB, Britto MCA de, Burity E, Rattes C, Reinaux CMA, Fink J, et al. Exhaled nitric oxide as a diagnostic tool for wheezing in preschool children: A diagnostic accuracy study. Respiratory Medicine. 2016 Apr 1;113:15-21.
https://doi.org/10.1016/j.rmed.2016.02.008
33. Blanco-Aparicio M, González-Barcala FJ, Padilla Galo A. [FENO measurement devices]. Open Respir Arch. 2022;4(4):100207.
https://doi.org/10.1016/j.opresp.2022.100207
34. Wyszyńska M, Nitsze-Wierzba M, Czelakowska A, Kasperski J, Żywiec J, Skucha-Nowak M. An Evidence-Based Review of Application Devices for Nitric Oxide Concentration Determination from Exhaled Air in the Diagnosis of Inflammation and Treatment Monitoring. Molecules. 2022 July 3;27(13):4279.
https://doi.org/10.3390/molecules27134279
35. Darbà J, Ascanio M, Syk J, Alving K. Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden. Clinicoecon Outcomes Res. 2021 Apr 23;13:289-97.
https://doi.org/10.2147/CEOR.S306389
36. Bonini M, Annibale R, Barbaglia S, Bo M, Capano F, Celeste M, et al. The role of Fraction Exhaled Nitric Oxide (FeNO) in asthma management: an Italian consensus statement on clinical and economic aspects. Multidiscip Respir Med. 2025 Apr 8;20(1):1006.
https://doi.org/10.5826/mrm.2025.1006
37. Lewis G, Morton K, Santillo M, Yardley L, Wang K, Ainsworth B, et al. Qualitative insights into planning implementation of FeNO-guided asthma management in primary care. NPJ Prim Care Respir Med. 2025 Mar 20;35:16.
https://doi.org/10.1038/s41533-025-00418-w
38. Buendía JA, Acuña-Cordero R, Rodriguez-Martinez CE. Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Effectiveness and Resource Allocation. 2021 June 3;19(1):33.
https://doi.org/10.1186/s12962-021-00287-3
39. Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89-97.
https://doi.org/10.18176/jiaci.0103
40. Fletcher MJ, Tsiligianni I, Kocks JWH, Cave A, Chunhua C, Sousa JC de, et al. Improving primary care management of asthma: do we know what really works? NPJ Prim Care Respir Med. 2020 June 17;30:29.
https://doi.org/10.1038/s41533-020-0184-0
41. Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, et al. The cost-effectiveness of FeNO testing for the diagnosis and management of asthma. In: Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath [Internet]. NIHR Journals Library; 2015 [cited 2025 Aug 31]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK321828/
https://doi.org/10.3310/hta19820
42. Rognoni C, Milano C, Heffler E, Bonini M, Brussino L, Carpagnano GE, et al. Economic impact of a more extensive use of FENO testing on the Italian population with asthma. Respir Res. 2023;24:147.
https://doi.org/10.1186/s12931-023-02437-y
43. Price D, Berg J, Lindgren P. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Allergy. 2009 Mar;64(3):431-8.
https://doi.org/10.1111/j.1398-9995.2008.01855.x
44. El Abd A, Dasari H, Dodin P, Trottier H, Ducharme FM. The effects of vitamin D supplementation on inflammatory biomarkers in patients with asthma: a systematic review and meta-analysis of randomized controlled trials. Front Immunol. 2024 Mar 13;15:1335968.
https://doi.org/10.3389/fimmu.2024.1335968
45. Lugogo N, Green CL, Agada N, Zhang S, Meghdadpour S, Zhou R, et al. Obesity's effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol. 2018 Mar;141(3):1096-104.
https://doi.org/10.1016/j.jaci.2017.04.047
46. Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial. Chest. 2012 Dec;142(6):1553-61.
https://doi.org/10.1378/chest.12-1310
47. Czubaj-Kowal M, Nowicki GJ, Kurzawa R, Polak M, Ślusarska B. Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8-9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb. Medicina (Kaunas). 2022 Jan 18;58(2):146.
https://doi.org/10.3390/medicina58020146
48. Barański K, Kocot K, Melaniuk-Wolny E, Zajusz-Zubek E, Kowalska M. The Effect of Physical Activity on Spirometry and Fractional Exhaled Nitric Oxide in Adolescents-Longitudinal Study. Sustainability. 2021 Jan;13(11):5770.
https://doi.org/10.3390/su13115770
49. Zhu Z, Xia S, Chen X, Guan WJ, Guo ZJ, Sun BQ. Factors associated with exhaled nitric oxide in children with asthma and allergic rhinitis. Clin Respir J. 2020 Jan;14(1):9-15.
https://doi.org/10.1111/crj.13093
50. Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res. 2015 May 20;9(3):036005.
https://doi.org/10.1088/1752-7155/9/3/036005
51. Wang D, Wang Y, Liang H, David JE, Bray CL. Race and ethnicity have significant influence on fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2018 Mar;120(3):272-277.e1.
https://doi.org/10.1016/j.anai.2017.11.021
52. Song WJ, Kim HJ, Shim JS, Won HK, Kang SY, Sohn KH, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis. J Allergy Clin Immunol. 2017 Sept;140(3):701-9.
https://doi.org/10.1016/j.jaci.2016.11.037
53. Kunc P, Fabry J, Zatko T, Grendar M, Tatar M, Pecova R. Cough reflex sensitivity and fractional exhaled nitric oxide in children with asthma. Physiol Res. 2020 Dec 31;69(Suppl 3):S455-61.
https://doi.org/10.33549/physiolres.934601
54. Maniscalco M, Ambrosino P, Poto R, Fuschillo S, Poto S, Matera MG, et al. Can FeNO be a biomarker in the post-COVID-19 patients monitoring? Respir Med. 2022 Mar;193:106745.
https://doi.org/10.1016/j.rmed.2022.106745
55. Moeller A, Carlsen KH, Sly PD, Baraldi E, Piacentini G, Pavord I, et al. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. Eur Respir Rev. 2015 June;24(136):204-15.
https://doi.org/10.1183/16000617.00003914
56. Oh MA, Shim JY, Jung YH, Seo JH, Young Kim H, Kwon JW, et al. Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol. 2013 June;48(6):563-70.
https://doi.org/10.1002/ppul.22705
57. Ferraro VA, Zanconato S, Baraldi E, Carraro S. Nitric Oxide and Biological Mediators in Pediatric Chronic Rhinosinusitis and Asthma. J Clin Med [Internet]. 2019 Oct 25 [cited 2020 Jan 6];8(11). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912805/
https://doi.org/10.3390/jcm8111783
58. Caudri D, Wijga AH, Hoekstra MO, Kerkhof M, Koppelman GH, Brunekreef B, et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax. 2010 Sept;65(9):801-7.
https://doi.org/10.1136/thx.2009.126912
59. Di Cara G, Marcucci F, Palomba A, Milioni M, Pecoraro L, Ciprandi G, et al. Exhaled nitric oxide in children with allergic rhinitis: a potential biomarker of asthma development. Pediatr Allergy Immunol. 2015 Feb;26(1):85-7.
https://doi.org/10.1111/pai.12326
60. Xepapadaki P, Adachi Y, Pozo Beltrán CF, El-Sayed ZA, Gómez RM, Hossny E, et al. Utility of biomarkers in the diagnosis and monitoring of asthmatic children. World Allergy Organ J. 2022 Dec 15;16(1):100727.
https://doi.org/10.1016/j.waojou.2022.100727
61. Wang X, Tan X, Li Q. Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta-analysis. Pediatr Pulmonol. 2020 Aug;55(8):1936-45.
https://doi.org/10.1002/ppul.24898
62. Fraser A, Simpson R, Turner S. Use of exhaled nitric oxide in the diagnosis and monitoring of childhood asthma: myth or maxim? Breathe (Sheff). 2023 Dec;19(4):220236.
https://doi.org/10.1183/20734735.0236-2022
63. Turner S, Cotton S, Wood J, Bell V, Raja EA, Scott NW, et al. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial. The Lancet Respiratory Medicine. 2022 June 1;10(6):584-92.
https://doi.org/10.1016/S2213-2600(21)00486-0
64. Hallas HW, Chawes BL, Rasmussen MA, Arianto L, Stokholm J, Bønnelykke K, et al. Airway obstruction and bronchial reactivity from age 1 month until 13 years in children with asthma: A prospective birth cohort study. PLoS Med. 2019 Jan;16(1):e1002722.
https://doi.org/10.1371/journal.pmed.1002722
65. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011 Sept 1;184(5):602-15.
https://doi.org/10.1164/rccm.9120-11ST
66. Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4).
https://doi.org/10.1183/13993003.00965-2016
67. Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7.
https://doi.org/10.1038/s41533-023-00330-1
68. Dinh-Thi-Dieu H, Vo-Thi-Kim A, Tran-Van H, Tang-Thi-Thao T, Duong-Quy S. Study of the beneficial role of exhaled nitric oxide in combination with GINA guidelines for titration of inhaled corticosteroids in children with asthma. J Breath Res. 2020 Mar 27;14(2):026014.
https://doi.org/10.1088/1752-7163/ab6809
69. Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax. 2017 Feb;72(2):109-16.
https://doi.org/10.1136/thoraxjnl-2016-208704
70. Pijnenburg MW. The Role of FeNO in Predicting Asthma. Front Pediatr. 2019;7:41.
https://doi.org/10.3389/fped.2019.00041
71. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention 2024 [Internet]. 2024. Available from: https://ginasthma.org/wp-content/uploads/2025/05/GINA-2024-strategy-report_24_05_22-WMSA.pdf
72. Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, et al. Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study. J Allergy Clin Immunol Pract. 2019 Jan;7(1):156-164.e1.
https://doi.org/10.1016/j.jaip.2018.04.043
73. Jackson D, Shackshaft L, Green L, Roxas C, Fernandes M, Thompson L, et al. The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab. European Respiratory Journal [Internet]. 2019 Sept 28 [cited 2023 June 18];54(suppl 63). Available from: https://erj.ersjournals.com/content/54/suppl_63/PA2623
https://doi.org/10.1183/13993003.congress-2019.PA2623
74. Yancey SW, Keene ON, Albers FC, Ortega H, Bates S, Bleecker ER, et al. Biomarkers for severe eosinophilic asthma. J Allergy Clin Immunol. 2017 Dec;140(6):1509-18.
https://doi.org/10.1016/j.jaci.2017.10.005
75. Shrimanker R, Keene O, Hynes G, Wenzel S, Yancey S, Pavord ID. Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis. Am J Respir Crit Care Med. 2019 Nov 15;200(10):1308-12.
https://doi.org/10.1164/rccm.201903-0599LE
76. Murugesan N, Saxena D, Dileep A, Adrish M, Hanania NA. Update on the Role of FeNO in Asthma Management. Diagnostics. 2023 Jan;13(8):1428.
https://doi.org/10.3390/diagnostics13081428
77. Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021 Oct;9(10):1165-73.
https://doi.org/10.1016/S2213-2600(21)00124-7
78. Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med. 2018 June 28;378(26):2486-96.
https://doi.org/10.1056/NEJMoa1804092
79. Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. New England Journal of Medicine. 2021 May 13;384(19):1800-9.
https://doi.org/10.1056/NEJMoa2034975
80. Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 May;75(5):1023-42.
https://doi.org/10.1111/all.14221
https://doi.org/10.1007/s00281-020-00785-1
2. Licari A, Castagnoli R, Brambilla I, Marseglia A, Tosca MA, Marseglia GL, et al. Asthma Endotyping and Biomarkers in Childhood Asthma. Pediatr Allergy Immunol Pulmonol. 2018 June 1;31(2):44-55.
https://doi.org/10.1089/ped.2018.0886
3. Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. Journal of Allergy and Clinical Immunology. 2012 Aug 1;130(2):287-96.
https://doi.org/10.1016/j.jaci.2012.04.025
4. Jat KR, Agarwal S. Lung Function Tests in Infants and Children. Indian J Pediatr. 2023 June 1;1-8.
https://doi.org/10.1007/s12098-023-04588-8
5. Elenius V, Chawes B, Malmberg PL, Adamiec A, Ruszczyński M, Feleszko W, et al. Lung function testing and inflammation markers for wheezing preschool children: A systematic review for the EAACI Clinical Practice Recommendations on Diagnostics of Preschool Wheeze. Pediatric Allergy and Immunology. 2021;32(3):501-13.
https://doi.org/10.1111/pai.13418
6. Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL. Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children. Chest. 2011 July;140(1):100-7.
https://doi.org/10.1378/chest.10-2794
7. Pande V, Thakur M. Emphasis on Quality of Life in Children and Adolescents With Bronchial Asthma. Cureus. 2024 Sept;16(9):e68762.
https://doi.org/10.7759/cureus.68762
8. Bhagat D, Fagnano M, Halterman JS, Reznik M. Asthma Symptoms, Interactive Physical Play, and Socio-emotional and Academic Outcomes in Urban Children with Persistent Asthma. J Asthma. 2019 July;56(7):711-8.
https://doi.org/10.1080/02770903.2018.1488978
9. Allen CW, Diamond-Myrsten S, Rollins LK. School Absenteeism in Children and Adolescents. Am Fam Physician. 2018 Dec 15;98(12):738-44.
10. Koinis-Mitchell D, Kopel SJ, Farrow ML, McQuaid EL, Nassau JH. Asthma and Academic Performance in Urban Children. Ann Allergy Asthma Immunol. 2019 May;122(5):471-7.
https://doi.org/10.1016/j.anai.2019.02.030
11. Hollander Z, DeMarco ML, Sadatsafavi M, McManus BM, Ng RT, Sin DD. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care. Chest. 2017 Feb;151(2):455-67.
https://doi.org/10.1016/j.chest.2016.09.012
12. Moreno-Jiménez E, Morgado N, Gómez-García M, Sanz C, Gil-Melcón M, Isidoro-García M, et al. TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences. 2025 Jan;26(3):1227.
https://doi.org/10.3390/ijms26031227
13. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018 27;391(10118):350-400.
https://doi.org/10.1016/S0140-6736(17)30879-6
14. Farne HA, Wilson A, Powell C, Bax L, Milan SJ. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017 Sept 21;9:CD010834.
https://doi.org/10.1002/14651858.CD010834.pub3
15. Agache I, Strasser DS, Klenk A, Agache C, Farine H, Ciobanu C, et al. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics. Allergy. 2016 Aug;71(8):1192-202.
https://doi.org/10.1111/all.12906
16. Williams TJ. Eotaxin-1 (CCL11). Front Immunol. 2015;6:84.
https://doi.org/10.3389/fimmu.2015.00084
17. Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG. Treatable Mechanisms in Asthma. Mol Diagn Ther. 2021;25(2):111-21.
https://doi.org/10.1007/s40291-021-00514-w
18. Jesenak M, Zelieskova M, Babusikova E. Oxidative Stress and Bronchial Asthma in Children-Causes or Consequences? Front Pediatr. 2017;5:162.
https://doi.org/10.3389/fped.2017.00162
19. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1376-81.
https://doi.org/10.1164/ajrccm.164.8.2101145
20. Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Agency for Healthcare Research and Quality; 2017 [cited 2021 Mar 19]. Available from: https://effectivehealthcare.ahrq.gov/topics/asthma-nitric-oxide/research/
https://doi.org/10.23970/AHRQEPCCER197
21. Hoyte FCL, Gross LM, Katial RK. Exhaled Nitric Oxide: An Update. Immunol Allergy Clin North Am. 2018 Nov;38(4):573-85.
https://doi.org/10.1016/j.iac.2018.06.001
22. Rao DR, Phipatanakul W. An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol. 2016 May;12(5):521-30.
https://doi.org/10.1586/1744666X.2016.1141049
23. Loewenthal L, Menzies-Gow A. FeNO in Asthma. Semin Respir Crit Care Med. 2022 Oct;43(5):635-45.
https://doi.org/10.1055/s-0042-1743290
24. Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr. 1997 Mar;130(3):423-7.
https://doi.org/10.1016/S0022-3476(97)70204-X
25. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997 Sept;131(3):381-5.
https://doi.org/10.1016/S0022-3476(97)80062-5
26. Nystad W, Samuelsen SO, Nafstad P, Edvardsen E, Stensrud T, Jaakkola JJK. Feasibility of measuring lung function in preschool children. Thorax. 2002 Dec;57(12):1021-7.
https://doi.org/10.1136/thorax.57.12.1021
27. Fenu G, Calogero C, Lombardi E. Lung Function Tests in Preschool Children. Turk Thorac J. 2015 Oct;16(4):185-8.
https://doi.org/10.5152/ttd.2015.5038
28. Gaffin JM, Shotola NL, Martin TR, Phipatanakul W. Clinically Useful Spirometry in Preschool-Aged Children: Evaluation of the 2007 American Thoracic Society Guidelines. J Asthma. 2010 Sept;47(7):762-7.
https://doi.org/10.3109/02770903.2010.485664
29. Heijkenskjöld-Rentzhog C, Kalm-Stephens P, Nordvall L, Malinovschi A, Alving K. New method for single-breath fraction of exhaled nitric oxide measurement with improved feasibility in preschool children with asthma. Pediatr Allergy Immunol. 2015 Nov;26(7):662-7.
https://doi.org/10.1111/pai.12447
30. Jackson DJ, Virnig CM, Gangnon RE, Evans MD, Roberg KA, Anderson EL, et al. Fractional Exhaled Nitric Oxide (FeNO) Measurements are Most Closely Associated with Allergic Sensitization in School Aged Children. J Allergy Clin Immunol. 2009 Nov;124(5):949-53.
https://doi.org/10.1016/j.jaci.2009.07.024
31. Vilmann L, Buchvald F, Green K, Nielsen KG. Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children. Respiratory Medicine. 2017 Dec 1;133:42-7.
https://doi.org/10.1016/j.rmed.2017.10.027
32. Sayão LB, Britto MCA de, Burity E, Rattes C, Reinaux CMA, Fink J, et al. Exhaled nitric oxide as a diagnostic tool for wheezing in preschool children: A diagnostic accuracy study. Respiratory Medicine. 2016 Apr 1;113:15-21.
https://doi.org/10.1016/j.rmed.2016.02.008
33. Blanco-Aparicio M, González-Barcala FJ, Padilla Galo A. [FENO measurement devices]. Open Respir Arch. 2022;4(4):100207.
https://doi.org/10.1016/j.opresp.2022.100207
34. Wyszyńska M, Nitsze-Wierzba M, Czelakowska A, Kasperski J, Żywiec J, Skucha-Nowak M. An Evidence-Based Review of Application Devices for Nitric Oxide Concentration Determination from Exhaled Air in the Diagnosis of Inflammation and Treatment Monitoring. Molecules. 2022 July 3;27(13):4279.
https://doi.org/10.3390/molecules27134279
35. Darbà J, Ascanio M, Syk J, Alving K. Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden. Clinicoecon Outcomes Res. 2021 Apr 23;13:289-97.
https://doi.org/10.2147/CEOR.S306389
36. Bonini M, Annibale R, Barbaglia S, Bo M, Capano F, Celeste M, et al. The role of Fraction Exhaled Nitric Oxide (FeNO) in asthma management: an Italian consensus statement on clinical and economic aspects. Multidiscip Respir Med. 2025 Apr 8;20(1):1006.
https://doi.org/10.5826/mrm.2025.1006
37. Lewis G, Morton K, Santillo M, Yardley L, Wang K, Ainsworth B, et al. Qualitative insights into planning implementation of FeNO-guided asthma management in primary care. NPJ Prim Care Respir Med. 2025 Mar 20;35:16.
https://doi.org/10.1038/s41533-025-00418-w
38. Buendía JA, Acuña-Cordero R, Rodriguez-Martinez CE. Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Effectiveness and Resource Allocation. 2021 June 3;19(1):33.
https://doi.org/10.1186/s12962-021-00287-3
39. Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89-97.
https://doi.org/10.18176/jiaci.0103
40. Fletcher MJ, Tsiligianni I, Kocks JWH, Cave A, Chunhua C, Sousa JC de, et al. Improving primary care management of asthma: do we know what really works? NPJ Prim Care Respir Med. 2020 June 17;30:29.
https://doi.org/10.1038/s41533-020-0184-0
41. Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, et al. The cost-effectiveness of FeNO testing for the diagnosis and management of asthma. In: Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath [Internet]. NIHR Journals Library; 2015 [cited 2025 Aug 31]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK321828/
https://doi.org/10.3310/hta19820
42. Rognoni C, Milano C, Heffler E, Bonini M, Brussino L, Carpagnano GE, et al. Economic impact of a more extensive use of FENO testing on the Italian population with asthma. Respir Res. 2023;24:147.
https://doi.org/10.1186/s12931-023-02437-y
43. Price D, Berg J, Lindgren P. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Allergy. 2009 Mar;64(3):431-8.
https://doi.org/10.1111/j.1398-9995.2008.01855.x
44. El Abd A, Dasari H, Dodin P, Trottier H, Ducharme FM. The effects of vitamin D supplementation on inflammatory biomarkers in patients with asthma: a systematic review and meta-analysis of randomized controlled trials. Front Immunol. 2024 Mar 13;15:1335968.
https://doi.org/10.3389/fimmu.2024.1335968
45. Lugogo N, Green CL, Agada N, Zhang S, Meghdadpour S, Zhou R, et al. Obesity's effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol. 2018 Mar;141(3):1096-104.
https://doi.org/10.1016/j.jaci.2017.04.047
46. Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial. Chest. 2012 Dec;142(6):1553-61.
https://doi.org/10.1378/chest.12-1310
47. Czubaj-Kowal M, Nowicki GJ, Kurzawa R, Polak M, Ślusarska B. Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8-9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb. Medicina (Kaunas). 2022 Jan 18;58(2):146.
https://doi.org/10.3390/medicina58020146
48. Barański K, Kocot K, Melaniuk-Wolny E, Zajusz-Zubek E, Kowalska M. The Effect of Physical Activity on Spirometry and Fractional Exhaled Nitric Oxide in Adolescents-Longitudinal Study. Sustainability. 2021 Jan;13(11):5770.
https://doi.org/10.3390/su13115770
49. Zhu Z, Xia S, Chen X, Guan WJ, Guo ZJ, Sun BQ. Factors associated with exhaled nitric oxide in children with asthma and allergic rhinitis. Clin Respir J. 2020 Jan;14(1):9-15.
https://doi.org/10.1111/crj.13093
50. Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res. 2015 May 20;9(3):036005.
https://doi.org/10.1088/1752-7155/9/3/036005
51. Wang D, Wang Y, Liang H, David JE, Bray CL. Race and ethnicity have significant influence on fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2018 Mar;120(3):272-277.e1.
https://doi.org/10.1016/j.anai.2017.11.021
52. Song WJ, Kim HJ, Shim JS, Won HK, Kang SY, Sohn KH, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis. J Allergy Clin Immunol. 2017 Sept;140(3):701-9.
https://doi.org/10.1016/j.jaci.2016.11.037
53. Kunc P, Fabry J, Zatko T, Grendar M, Tatar M, Pecova R. Cough reflex sensitivity and fractional exhaled nitric oxide in children with asthma. Physiol Res. 2020 Dec 31;69(Suppl 3):S455-61.
https://doi.org/10.33549/physiolres.934601
54. Maniscalco M, Ambrosino P, Poto R, Fuschillo S, Poto S, Matera MG, et al. Can FeNO be a biomarker in the post-COVID-19 patients monitoring? Respir Med. 2022 Mar;193:106745.
https://doi.org/10.1016/j.rmed.2022.106745
55. Moeller A, Carlsen KH, Sly PD, Baraldi E, Piacentini G, Pavord I, et al. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. Eur Respir Rev. 2015 June;24(136):204-15.
https://doi.org/10.1183/16000617.00003914
56. Oh MA, Shim JY, Jung YH, Seo JH, Young Kim H, Kwon JW, et al. Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol. 2013 June;48(6):563-70.
https://doi.org/10.1002/ppul.22705
57. Ferraro VA, Zanconato S, Baraldi E, Carraro S. Nitric Oxide and Biological Mediators in Pediatric Chronic Rhinosinusitis and Asthma. J Clin Med [Internet]. 2019 Oct 25 [cited 2020 Jan 6];8(11). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912805/
https://doi.org/10.3390/jcm8111783
58. Caudri D, Wijga AH, Hoekstra MO, Kerkhof M, Koppelman GH, Brunekreef B, et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax. 2010 Sept;65(9):801-7.
https://doi.org/10.1136/thx.2009.126912
59. Di Cara G, Marcucci F, Palomba A, Milioni M, Pecoraro L, Ciprandi G, et al. Exhaled nitric oxide in children with allergic rhinitis: a potential biomarker of asthma development. Pediatr Allergy Immunol. 2015 Feb;26(1):85-7.
https://doi.org/10.1111/pai.12326
60. Xepapadaki P, Adachi Y, Pozo Beltrán CF, El-Sayed ZA, Gómez RM, Hossny E, et al. Utility of biomarkers in the diagnosis and monitoring of asthmatic children. World Allergy Organ J. 2022 Dec 15;16(1):100727.
https://doi.org/10.1016/j.waojou.2022.100727
61. Wang X, Tan X, Li Q. Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta-analysis. Pediatr Pulmonol. 2020 Aug;55(8):1936-45.
https://doi.org/10.1002/ppul.24898
62. Fraser A, Simpson R, Turner S. Use of exhaled nitric oxide in the diagnosis and monitoring of childhood asthma: myth or maxim? Breathe (Sheff). 2023 Dec;19(4):220236.
https://doi.org/10.1183/20734735.0236-2022
63. Turner S, Cotton S, Wood J, Bell V, Raja EA, Scott NW, et al. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial. The Lancet Respiratory Medicine. 2022 June 1;10(6):584-92.
https://doi.org/10.1016/S2213-2600(21)00486-0
64. Hallas HW, Chawes BL, Rasmussen MA, Arianto L, Stokholm J, Bønnelykke K, et al. Airway obstruction and bronchial reactivity from age 1 month until 13 years in children with asthma: A prospective birth cohort study. PLoS Med. 2019 Jan;16(1):e1002722.
https://doi.org/10.1371/journal.pmed.1002722
65. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011 Sept 1;184(5):602-15.
https://doi.org/10.1164/rccm.9120-11ST
66. Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4).
https://doi.org/10.1183/13993003.00965-2016
67. Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7.
https://doi.org/10.1038/s41533-023-00330-1
68. Dinh-Thi-Dieu H, Vo-Thi-Kim A, Tran-Van H, Tang-Thi-Thao T, Duong-Quy S. Study of the beneficial role of exhaled nitric oxide in combination with GINA guidelines for titration of inhaled corticosteroids in children with asthma. J Breath Res. 2020 Mar 27;14(2):026014.
https://doi.org/10.1088/1752-7163/ab6809
69. Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax. 2017 Feb;72(2):109-16.
https://doi.org/10.1136/thoraxjnl-2016-208704
70. Pijnenburg MW. The Role of FeNO in Predicting Asthma. Front Pediatr. 2019;7:41.
https://doi.org/10.3389/fped.2019.00041
71. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention 2024 [Internet]. 2024. Available from: https://ginasthma.org/wp-content/uploads/2025/05/GINA-2024-strategy-report_24_05_22-WMSA.pdf
72. Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, et al. Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study. J Allergy Clin Immunol Pract. 2019 Jan;7(1):156-164.e1.
https://doi.org/10.1016/j.jaip.2018.04.043
73. Jackson D, Shackshaft L, Green L, Roxas C, Fernandes M, Thompson L, et al. The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab. European Respiratory Journal [Internet]. 2019 Sept 28 [cited 2023 June 18];54(suppl 63). Available from: https://erj.ersjournals.com/content/54/suppl_63/PA2623
https://doi.org/10.1183/13993003.congress-2019.PA2623
74. Yancey SW, Keene ON, Albers FC, Ortega H, Bates S, Bleecker ER, et al. Biomarkers for severe eosinophilic asthma. J Allergy Clin Immunol. 2017 Dec;140(6):1509-18.
https://doi.org/10.1016/j.jaci.2017.10.005
75. Shrimanker R, Keene O, Hynes G, Wenzel S, Yancey S, Pavord ID. Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis. Am J Respir Crit Care Med. 2019 Nov 15;200(10):1308-12.
https://doi.org/10.1164/rccm.201903-0599LE
76. Murugesan N, Saxena D, Dileep A, Adrish M, Hanania NA. Update on the Role of FeNO in Asthma Management. Diagnostics. 2023 Jan;13(8):1428.
https://doi.org/10.3390/diagnostics13081428
77. Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021 Oct;9(10):1165-73.
https://doi.org/10.1016/S2213-2600(21)00124-7
78. Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med. 2018 June 28;378(26):2486-96.
https://doi.org/10.1056/NEJMoa1804092
79. Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. New England Journal of Medicine. 2021 May 13;384(19):1800-9.
https://doi.org/10.1056/NEJMoa2034975
80. Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 May;75(5):1023-42.
https://doi.org/10.1111/all.14221